KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Astrazeneca (AZN) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Astrazeneca (AZN) over the last 17 years, with Q4 2025 value amounting to 0.51.

  • Astrazeneca's Asset Utilization Ratio fell 67.47% to 0.51 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.51, marking a year-over-year decrease of 67.47%. This contributed to the annual value of 0.54 for FY2025, which is 217.68% up from last year.
  • As of Q4 2025, Astrazeneca's Asset Utilization Ratio stood at 0.51, which was down 67.47% from 0.51 recorded in Q3 2025.
  • Over the past 5 years, Astrazeneca's Asset Utilization Ratio peaked at 0.7 during Q4 2021, and registered a low of 0.12 during Q4 2022.
  • In the last 5 years, Astrazeneca's Asset Utilization Ratio had a median value of 0.47 in 2023 and averaged 0.42.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first tumbled by 8290.29% in 2022, then skyrocketed by 28972.68% in 2023.
  • Over the past 5 years, Astrazeneca's Asset Utilization Ratio (Quarter) stood at 0.7 in 2021, then crashed by 82.9% to 0.12 in 2022, then soared by 289.73% to 0.46 in 2023, then increased by 11.4% to 0.52 in 2024, then dropped by 0.67% to 0.51 in 2025.
  • Its last three reported values are 0.51 in Q4 2025, 0.51 for Q3 2025, and 0.52 during Q2 2025.